Bioengineering Human Tissues and the Future of Vascular Replacement.

Authors:
Naegeli KM; Kural MH; Li Y; Wang J; Hugentobler EA and 1 more

Journal:
Circ Res

Publication Year: 2022

DOI:
10.1161/CIRCRESAHA.121.319984

PMCID:
PMC9213087

PMID:
35737757

Journal Information

Full Title: Circ Res

Abbreviation: Circ Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures L.E. Niklason is a founder, shareholder, President, and CEO of Humacyte, Inc, and serves on Humacyte’s Board of Directors. L.E. Niklason’s spouse is a shareholder of Humacyte, Inc, and serves on the Board of Directors. Y. Li, M.H. Kural, E.A. Hugentobler, J. Wang, and K.M. Naegeli are shareholders and employees of Humacyte, Inc."

Evidence found in paper:

"Sources of Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025